Keyphrases
Liposomes
100%
Doxorubicin-loaded
100%
Phosphatidylethanolamine
100%
Hydrogenated
100%
Immunoliposomes
100%
Specific Antibodies
66%
Polyethylene Glycol
66%
IgG3
66%
Cell-based
33%
Soy Phosphatidylcholine
33%
Specific Binding
33%
Minimal Impact
33%
Cholesterol
33%
Immunoglobulin
33%
Macrophages
33%
Tumor Cells
33%
Doxorubicin
33%
Tumor Antigen
33%
Surface Mounting
33%
Intravenous Administration
33%
Chemical Stability
33%
Polyomavirus
33%
Binding Specificity
33%
Thioether Bond
33%
Physical Stability
33%
Cell Uptake
33%
Non-specific Binding
33%
Tumor Targeting
33%
Unilamellar Liposomes
33%
Dosage Forms
33%
Primary Amino Groups
33%
Cell-type Specificity
33%
Murine Fibrosarcoma
33%
Prolonged Circulation Time
33%
Loaded Liposomes
33%
Plasma Pharmacokinetics
33%
Fibrosarcoma Cells
33%
Slow Clearance
33%
Ammonium Sulfate Gradient
33%
Prolonged Circulation
33%
Neuroscience
Phosphatidylethanolamine
100%
Immunoliposome
100%
Doxorubicin
100%
Macrogol
66%
Immunoglobulin G3
66%
In Vivo
33%
In Vitro
33%
Macrophage
33%
Lecithin
33%
Thioether
33%
Tumor Antigen
33%
Polyomavirus
33%
Blood Plasma
33%
Pharmacokinetic
33%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Liposome
100%
Immunoliposome
100%
Phosphatidylethanolamine
60%
Neoplasm
40%
Macrogol
40%
Immunoglobulin G3
40%
Ammonium Sulfate
20%
Tumor Antigen
20%
Thioether
20%
Dosage Forms
20%
Fibrosarcoma
20%
Egg Lecithin
20%
Polyomavirus
20%
Pharmacokinetics
20%
Biochemistry, Genetics and Molecular Biology
Doxorubicin
100%
Phosphatidylethanolamine
100%
Target Cell
66%
Ammonium Sulfate
33%
Immunoglobulin
33%
Macrophage
33%
Pharmacokinetics
33%
Thioether
33%
Tumor Antigen
33%
Drug Blood Level
33%
Polyomavirus
33%
Lecithin
33%